| Ashley Dawn Martin, FNP-C | |
|
2240 Tug Valley Dr, Williamson, WV 25661-9652 | |
| (304) 928-1974 | |
| Not Available |
| Full Name | Ashley Dawn Martin |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 2240 Tug Valley Dr, Williamson, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780364638 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 4007448 (Kentucky) | Primary |
| Entity Name | Floyd Emergency Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760834345 PECOS PAC ID: 6608164488 Enrollment ID: O20161011001337 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
Researchers in Germany have finished the first complete analysis of the "molecular machines" in one of biology's most important model organisms: S. cerevisiae (baker's yeast). The study from the biotechnology company Cellzome, in collaboration with the European Molecular Biology Laboratory (EMBL), appears in this week's online edition of Nature.
Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene. Traditional treatment options, such as enzyme replacement therapy, are of limited efficacy, but bone marrow transplant from a compatible donor leads to a better response.
To seek answers, the National Human Genome Research Institute and the National Institute of Mental Health has named the University of North Carolina at Chapel Hill a Center of Excellence in Genomic Science and awarded UNC $8.6 million over five years to fund a new Center for Integrated Systems Genetics, or CISGen.
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Dawn Martin, FNP-C 2240 Tug Valley Dr, Williamson, WV 25661-9652 Ph: (304) 928-1974 | Ashley Dawn Martin, FNP-C 2240 Tug Valley Dr, Williamson, WV 25661-9652 Ph: (304) 928-1974 |
News Archive
The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $1 million to each of three Boston-area biotech companies through its 2010 Biotech Investment Awards program: Constellation Pharmaceuticals, Inc., Epizyme, Inc. and Karyopharm Therapeutics, Inc. Since the inception of this MMRF program in 2006, $11 million has been committed to 11 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.
Researchers in Germany have finished the first complete analysis of the "molecular machines" in one of biology's most important model organisms: S. cerevisiae (baker's yeast). The study from the biotechnology company Cellzome, in collaboration with the European Molecular Biology Laboratory (EMBL), appears in this week's online edition of Nature.
Severe combined immunodeficiency is defect in the immune system that results in a loss of the adaptive immune cells known as B cells and T cells. Mutations in several different genes can lead to the development of severe combined immunodeficiency, including mutation of the adenosine deaminase (ADA) gene. Traditional treatment options, such as enzyme replacement therapy, are of limited efficacy, but bone marrow transplant from a compatible donor leads to a better response.
To seek answers, the National Human Genome Research Institute and the National Institute of Mental Health has named the University of North Carolina at Chapel Hill a Center of Excellence in Genomic Science and awarded UNC $8.6 million over five years to fund a new Center for Integrated Systems Genetics, or CISGen.
In a large analysis of men participating in a prostate drug trial, researchers at the Duke Cancer Institute found a significant correlation between coronary artery disease and prostate cancer, suggesting the two conditions may have shared causes.
› Verified 8 days ago
Tina Lee Brown-cohenour, MSN RN, APRN FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 184 E 2nd Ave Ste 210, Williamson, WV 25661 Phone: 304-236-5902 Fax: 855-487-4047 | |
Mrs. Tiara Lyn Ferrell, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 160 E 2nd Ave, Williamson, WV 25661 Phone: 304-784-7165 | |
Jennifer Kay Mcpeek, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 104 Logan St, Williamson, WV 25661 Phone: 304-236-5902 | |
Mrs. Aimee Michelle Colegrove, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 872 Route 65, Williamson, WV 25661 Phone: 304-475-3700 Fax: 304-475-3780 | |
Deborah Gail Epling, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 184 E 2nd Ave Ste 210, Williamson, WV 25661 Phone: 304-236-5902 | |
Traci Thornsbury, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 104 Logan St Ste A, Williamson, WV 25661 Phone: 304-236-5902 | |
Traci Lynn Booth, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 184 E 2nd Ave Ste 1, Williamson, WV 25661 Phone: 304-235-2930 Fax: 304-235-2933 |